Clinical Cancer Research  Stand Up to Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 14, 4767-4774, August 1, 2008. doi: 10.1158/1078-0432.CCR-07-4715
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Ludwig, N.
Right arrow Articles by Meese, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ludwig, N.
Right arrow Articles by Meese, E.

Imaging, Diagnosis, Prognosis

Pattern of Serum Autoantibodies Allows Accurate Distinction between a Tumor and Pathologies of the Same Organ

Nicole Ludwig1, Andreas Keller4, Nicole Comtesse1, Stefanie Rheinheimer1, Christian Pallasch5, Ulrike Fischer1, Klaus Fassbender2, Wolf Ingo Steudel3, Hans-Peter Lenhof4 and Eckart Meese1

Authors' Affiliations: Departments of 1 Human Genetics, 2 Neurology, and 3 Neurosurgery, Medical School, Saarland University, Homburg/Saar, Germany; 4 Center for Bioinformatics, Saarland University, Saarbrücken, Germany; and 5 Department of Internal Medicine I, University of Cologne, Köln, Germany

Requests for reprints: Eckart Meese, Department of Human Genetics, Medical School, Saarland University, Kirrberger Strasse, Homburg 66421, Germany. Phone: 49-6841-1626038; Fax: 49-6841-1626185; E-mail: hgemee{at}uniklinik-saarland.de.

Purpose: Recent studies impressively showed the diagnostic potential of seroreactivity patterns for different tumor types, offering the prospect for low-cost screening of numerous tumor types simultaneously. One of the major challenges toward this goal is to prove that seroreactivity profiles do not only allow for identifying a tumor but also allow for distinguishing tumors from other pathologies of the same organ.

Experimental Design: We chose glioma as a model system and tested 325 sera (88 glioma, 95 intracranial tumors, 60 other brain pathologies, and 82 healthy controls) for seroreactivity on a panel of 35 antigens.

Results: We were able to discriminate between glioma and all other sera with cross-validated specificity of 86.1%, sensitivity of 85.2%, and accuracy of 85.8%. We obtained comparably good results for the separation of glioma versus nontumor brain pathologies and glioma versus other intracranial tumors.

Conclusion: Our study provides first evidence that seroreactivity patterns allow for an accurate discrimination between a tumor and pathologies of the same organ even between different tumor types of the same organ.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.